UroGen Pharma (URGN) EPS (Basic) (2017 - 2026)
UroGen Pharma (URGN) posted EPS (Basic) of -$0.47 for Q1 2026, up 14.58% on a QoQ basis from -$0.55 in Q4 2025, and up 49.19% year-over-year from -$0.31 in Q1 2025.
UroGen Pharma (URGN) EPS (Basic) (2017 - 2026) Analysis & Trends
UroGen Pharma's EPS (Basic) history runs 10 years deep, the most recent figure standing at -$0.47 for Q1 2026.
- Quarterly EPS (Basic) rose 49.19% year-over-year to -$0.47 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.66 (down 17.67% YoY) and the FY2025 annual result came in at -$3.19, down 43.3% from the prior year.
- EPS (Basic) was -$0.47 for Q1 2026 at UroGen Pharma, up from -$0.55 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.14 in Q4 2024 and bottomed at -$1.3 in Q1 2023.
- A 5-year average of -$0.89 and a median of -$0.96 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) plunged 1430.71% — and 2024, when it soared 85.12%.
- UroGen Pharma's EPS (Basic) stood at -$1.27 in 2022, then advanced by 23.83% to -$0.96 in 2023, then surged by 85.12% to -$0.14 in 2024, then plunged by 283.41% to -$0.55 in 2025, then climbed by 14.58% to -$0.47 in 2026.
- Business Quant data shows URGN's EPS (Basic) at -$0.47 in Q1 2026, -$0.55 in Q4 2025, and -$0.69 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | UroGen Pharma | 2.05 Bn | 1.91 Bn | 46.82 Mn | -0.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.47 |
| Dec 31, 2025 | -0.55 |
| Sep 30, 2025 | -0.69 |
| Jun 30, 2025 | -1.05 |
| Mar 31, 2025 | -0.92 |
| Dec 31, 2024 | -0.14 |
| Sep 30, 2024 | -0.55 |
| Jun 30, 2024 | -0.91 |
| Mar 31, 2024 | -0.97 |
| Dec 31, 2023 | -0.96 |
| Sep 30, 2023 | -0.68 |
| Jun 30, 2023 | -1.03 |
| Mar 31, 2023 | -1.30 |
| Dec 31, 2022 | -1.27 |
| Sep 30, 2022 | -1.13 |
| Jun 30, 2022 | -1.18 |
| Mar 31, 2022 | -1.25 |
| Dec 31, 2021 | -0.08 |
| Sep 30, 2021 | -1.35 |
| Jun 30, 2021 | -1.17 |